Propanc Biopharma Files 10-Q for Q3 2025
Ticker: PPCB · Form: 10-Q · Filed: May 15, 2025 · CIK: 1517681
| Field | Detail |
|---|---|
| Company | Propanc Biopharma, Inc. (PPCB) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biopharma
TL;DR
Propanc Biopharma filed its Q3 2025 10-Q. Check financials.
AI Summary
Propanc Biopharma, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and business operations for the third quarter of their fiscal year. Key financial data and disclosures relevant to investors are presented in this report.
Why It Matters
This 10-Q filing provides crucial financial and operational updates for Propanc Biopharma, Inc., offering insights into the company's performance and financial health for the third quarter of fiscal year 2025.
Risk Assessment
Risk Level: medium — As a biopharmaceutical company, Propanc Biopharma operates in a highly regulated and competitive industry, facing inherent risks related to drug development, clinical trials, and market approval.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-15 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Propanc Biopharma, Inc. (company) — Filer of the 10-Q report
- 20250331 (date) — End of the reporting period
- 20250515 (date) — Filing date of the report
- 302/6 BUTLER STREET, CAMBERWELL, VICTORIA (address) — Company's business and mailing address
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 15, 2025.
What is the company's fiscal year end?
The company's fiscal year ends on June 30.
What is the company's business address?
The company's business address is 302/6 BUTLER STREET, CAMBERWELL, VICTORIA, C3, 3124.
What is the Standard Industrial Classification code for Propanc Biopharma, Inc.?
The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Propanc Biopharma, Inc. (PPCB).